These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 10623661)
1. Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. Wyss-Coray T; Lin C; Sanan DA; Mucke L; Masliah E Am J Pathol; 2000 Jan; 156(1):139-50. PubMed ID: 10623661 [TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease-like cerebrovascular pathology in transforming growth factor-beta 1 transgenic mice and functional metabolic correlates. Wyss-Coray T; Lin C; von Euw D; Masliah E; Mucke L; Lacombe P Ann N Y Acad Sci; 2000 Apr; 903():317-23. PubMed ID: 10818521 [TBL] [Abstract][Full Text] [Related]
3. Molecular and functional dissection of TGF-beta1-induced cerebrovascular abnormalities in transgenic mice. Buckwalter M; Pepper JP; Gaertner RF; Von Euw D; Lacombe P; Wyss-Coray T Ann N Y Acad Sci; 2002 Nov; 977():87-95. PubMed ID: 12480736 [TBL] [Abstract][Full Text] [Related]
4. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease. Wyss-Coray T; Masliah E; Mallory M; McConlogue L; Johnson-Wood K; Lin C; Mucke L Nature; 1997 Oct; 389(6651):603-6. PubMed ID: 9335500 [TBL] [Abstract][Full Text] [Related]
5. Cerebrovascular pathology during the progression of experimental Alzheimer's disease. Giannoni P; Arango-Lievano M; Neves ID; Rousset MC; Baranger K; Rivera S; Jeanneteau F; Claeysen S; Marchi N Neurobiol Dis; 2016 Apr; 88():107-17. PubMed ID: 26774030 [TBL] [Abstract][Full Text] [Related]
6. TGF-β1 factor in the cerebrovascular diseases of Alzheimer's disease. Zhang X; Huang WJ; Chen WW Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5178-5185. PubMed ID: 28051272 [TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in transgenic mice. Lesné S; Docagne F; Gabriel C; Liot G; Lahiri DK; Buée L; Plawinski L; Delacourte A; MacKenzie ET; Buisson A; Vivien D J Biol Chem; 2003 May; 278(20):18408-18. PubMed ID: 12626500 [TBL] [Abstract][Full Text] [Related]
8. Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease. Bourasset F; Ouellet M; Tremblay C; Julien C; Do TM; Oddo S; LaFerla F; Calon F Neuropharmacology; 2009 Mar; 56(4):808-13. PubMed ID: 19705573 [TBL] [Abstract][Full Text] [Related]
9. Vascular remodeling versus amyloid beta-induced oxidative stress in the cerebrovascular dysfunctions associated with Alzheimer's disease. Tong XK; Nicolakakis N; Kocharyan A; Hamel E J Neurosci; 2005 Nov; 25(48):11165-74. PubMed ID: 16319316 [TBL] [Abstract][Full Text] [Related]
10. Transgenic mice overexpressing APP and transforming growth factor-beta1 feature cognitive and vascular hallmarks of Alzheimer's disease. Ongali B; Nicolakakis N; Lecrux C; Aboulkassim T; Rosa-Neto P; Papadopoulos P; Tong XK; Hamel E Am J Pathol; 2010 Dec; 177(6):3071-80. PubMed ID: 21088218 [TBL] [Abstract][Full Text] [Related]
11. Functional role of TGF beta in Alzheimer's disease microvascular injury: lessons from transgenic mice. Masliah E; Ho G; Wyss-Coray T Neurochem Int; 2001; 39(5-6):393-400. PubMed ID: 11578774 [TBL] [Abstract][Full Text] [Related]
12. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Wyss-Coray T; Lin C; Yan F; Yu GQ; Rohde M; McConlogue L; Masliah E; Mucke L Nat Med; 2001 May; 7(5):612-8. PubMed ID: 11329064 [TBL] [Abstract][Full Text] [Related]
13. Selective in vivo antagonism of endothelin receptors in transforming growth factor-beta1 transgenic mice that mimic the vascular pathology of Alzheimer's disease. Papadopoulos P; Ongali B; Hamel E Can J Physiol Pharmacol; 2010 Jun; 88(6):652-60. PubMed ID: 20628431 [TBL] [Abstract][Full Text] [Related]
15. Reduced brain tissue perfusion in TGF-beta 1 transgenic mice showing Alzheimer's disease-like cerebrovascular abnormalities. Gaertner RF; Wyss-Coray T; Von Euw D; Lesné S; Vivien D; Lacombe P Neurobiol Dis; 2005; 19(1-2):38-46. PubMed ID: 15837559 [TBL] [Abstract][Full Text] [Related]
16. Cerebral circulation: function and dysfunction in Alzheimer's disease. Hamel E J Cardiovasc Pharmacol; 2015 Apr; 65(4):317-24. PubMed ID: 25384195 [TBL] [Abstract][Full Text] [Related]
17. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease. Kuznetsova E; Schliebs R Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514 [TBL] [Abstract][Full Text] [Related]
18. Altered expression of basement membrane-related molecules in rat brain pericyte, endothelial, and astrocyte cell lines after transforming growth factor-beta1 treatment. Kose N; Asashima T; Muta M; Iizasa H; Sai Y; Terasaki T; Nakashima E Drug Metab Pharmacokinet; 2007 Aug; 22(4):255-66. PubMed ID: 17827780 [TBL] [Abstract][Full Text] [Related]
19. Losartan improves cerebrovascular function in a mouse model of Alzheimer's disease with combined overproduction of amyloid-β and transforming growth factor-β1. Papadopoulos P; Tong XK; Imboden H; Hamel E J Cereb Blood Flow Metab; 2017 Jun; 37(6):1959-1970. PubMed ID: 27389178 [TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta1 stimulates the synthesis of basement membrane proteins laminin, collagen type IV and entactin in rat liver sinusoidal endothelial cells. Neubauer K; Krüger M; Quondamatteo F; Knittel T; Saile B; Ramadori G J Hepatol; 1999 Oct; 31(4):692-702. PubMed ID: 10551394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]